InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
首席执行官已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the full record of transactions filed by Simonian Nancy A, 董事长兼首席执行官. Insider active across 2 companies, notably Seagen Inc.. In total, 14 disclosures have been recorded. Split: 0 buy · 2 sells. Activity tracked since 14 May 2021. The latest transaction was disclosed on 5 June 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Simonian Nancy A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报14 总计
37,070 股@ €0.25629.2% 占其流量Common StockSEC:0000950170-24-133338:0
134,713 股@ €0.253233.1% 占其流量Common StockSEC:0000950170-24-131591:0
40,125 股Common StockSEC:0000950170-24-120874:0
4,000 股0Common StockSEC:0000950170-24-070706:0
6,000 股Common StockSEC:0000950170-24-040308:0
62,753 股@ US$229.0094.6% 占其流量Common StockSEC:0000950170-23-070884:0
40,125 股Common StockSEC:0001209191-23-054174:0
2,044 股0Common StockSEC:0001203311-23-000059:0
6,000 股Common StockSEC:0001209191-23-022969:0
8,750 股@ US$36.702.2% 占其流量Common StockSEC:0001203311-22-000065:0
1,503 股0Common StockSEC:0000899243-22-018458:0
58,883 股@ €1.0115100.0% 占其流量Common StockSEC:0001209191-22-022499:0
25,000 股@ US$20.04100.0% 占其流量Common StockSEC:0000899243-22-009424:0
1,402 股0Common StockSEC:0001203311-21-000036:0
14 条申报中的 14 条
About Simonian Nancy A
Simonian Nancy A is President and Chief Executive Officer and serves as a director at Syros Pharmaceuticals, Inc. and Seagen Inc. The declarant has 14 filings in total, and in the recent filings tracked, sell volume amounts to EUR 13200684, covering the period from 2021-05-18 to 2024-12-04, with the most frequent transaction nature listed as option exercise.
